Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date6/7/21 → …